Analysis of Plasma EBV-DNA and Soluble Checkpoint Proteins in Nasopharyngeal Carcinoma Patients after Definitive Intensity-Modulated Radiotherapy.

Conclusions: This study demonstrated that the concentration of sPD-1 was significantly increased and EBV-DNA was significantly reduced in the NPC patients after IMRT. Plasma EBV-DNA level was a highly specific and sensitive biomarker for NPC diagnosis. Both sPD-1 expression and EBV-DNA concentration in plasma were related to the survival of patients. PMID: 31192256 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31192256?dopt=Abstract

Source: Biomed Res - June 14, 2019 Category: Research Authors: Ruan Y, Hu W, Li W, Lu H, Gu H, Zhang Y, Zhu C, Chen Q Tags: Biomed Res Int Source Type: research